Skip to content
Aton
EN
FR
EN
FR
Home
About Us
Our Strategy
Our Platforms
Open menu
Our Platforms
Preclinical & Clinical Services
Monoclonal Antibodies Production
Laboratory Equipment Production
Human Tissue Provision
Insights & News
Contact Us
Investors
Newsletter Signup
Inoviem Scientific takes control of Bcell Design and Arkab
Half-year results 2021
Extension of INSERN collaboration contract on SDRA
Hybrigenics makes contact with Bone Therapeutics with a view to a partnership
Project to acquire a stake in Inoviem Scientific
Inoviem Scientific entry protocol signature
Annual results 2020
Letter to shareholders
Recent activities and areas for development
Half-year results 2020